Apigenin, a flavonoid compound, has been shown to reduce the levels of mRNA and protein of Nrf2 through the downregulation of the PI3K/AKT pathway, and thereby sensitizing cancer cells that are resistant to doxorubicin by inducing apoptosis [184]. This evidence concerns the gene AKT1 and cancer.